Glucose Production in Health and Type 2 Diabetes: Measurement,Regulation,and Molecular Basis. An Overview

International Diabetes Federation IGT/IFG consensus statement. Report of an expert consensus workshop; 2001 August 1–4; Stoke Poges, UK. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002; 19: 708–23.

Schianca G.P. , Maduli E. , Rossi A. The significance of impaired fasting versus impaired glucose tolerance. Importance of insulin secretion and resistance. Diabetes Care 2003; 26: 1333–7.

Radziuk J. , Pye S. Endogenous glucose production in type 2 diabetes: basal and postprandial. Role of diurnal rhythms. Presented at Experimental Biology 2004; April 17–21; Washington, DC.

Basu A. , Shah P. , Nielsen M. Effects of type 2 diabetes on the regulation of hepatic glucose metabolism. Presented at Experimental Biology 2004; April 17–21; Washington, DC.

Radziuk J. , Pye S. Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis. Diabetes Metab Res Rev 2001; 17: 250–72.

Boden G. Gluconeogenesis and glycogenosis in health and diabetes. Presented at Experimental Biology 2004; April 17–21; Washington, DC.

Proietto J. , Andrikopoulos S. Molecular mechanisms of increased glucose production: identifying potential therapeutic targets. Presented at Experimental Biology 2004; April 17–21; Washington, DC.

Sloop K.W. , Cao J.X.-C , Siesky A. Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors. J Clin Invest 2004; 113: 1571–81.

Link J.T. Pharmacological regulation of hepatic glucose production. Curr Opin Invest Drugs 2003; 4: 421–9.